English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 23 September 2019, 08:00 HKT/SGT
Share:
    

Source: Woodbridge
Woodbridge Buys-Out Joint Venture Partner in China to Enhance Regional Growth Opportunities

TROY, MI, Sept 23, 2019 - (ACN Newswire) - Woodbridge, a global systems solution provider of fully-integrated foam products, announces it has entered into a formal agreement to acquire all the shares in its joint venture, Woodbridge GSK High Polymer Technology Co., Ltd. (WGSK), from its partner GSK Corporation. The transaction will enable Woodbridge to enhance its growth opportunities with its customers located in China.

Upon regulatory approval, GSK's shares will be transferred to Woodbridge. The acquisition includes molded foam manufacturing operations in China: Wuhan (WGSK), Guangzhou (Guangzhou Woodbridge GSK High Polymer Technology Co., Ltd.) and Shanghai (Shanghai Woodbridge GSK Auto Parts Co., Ltd.).

"Woodbridge has been the management partner and technology provider of these three sites for 14 years," said Woodbridge president and CEO Charles Daly. "These facilities will allow our technical expertise, operational excellence and proven track record to continue to be a powerful platform to accelerate growth within the region."

According to Greg Yan, Woodbridge general manager, China, "On behalf of the entire team, I would like to thank GSK for their partnership and wish them continued success. Today marks an exciting chapter for us and reflects the collective efforts of our entire team and we look forward to our future in China."

Following the completion of the sale, Woodbridge will continue to supply molded foam to GSK's seat assembly operations.

About Woodbridge

Woodbridge is a privately-owned company offering innovative material technologies for applications in automotive, commercial, recreational, packaging, healthcare and building products. In addition to its manufacturing operations, Woodbridge offers a full complement of services including: chemical research and development, product and process engineering, tooling, technical support and accredited laboratory testing. Woodbridge operates more than 60 facilities across 10 countries-employing over 7,500 teammates and serving more than 600 customers worldwide. To learn more, visit woodbridgegroup.com.

Media Contacts:
Eric Turmel, Marketing Manager
(248) 280-6322
eric_turmel@woodbridgegroup.com

Greg Yan, General Manager, China
011-86-21-3173-5912, ext. 6522
greg_yan@woodbridgegroup.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/48006

Topic: Press release summary
Source: Woodbridge

Sectors: Chemicals, Spec.Chem, Funds & Equities, PE, VC & Alternatives
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
KOSPET Launches M3 Ultra and T3 Ultra Rugged Smartwatches in Malaysia, Redefining Durability and Innovation  
Nov 26, 2024 13:45 HKT/SGT
TOPVISION Launches Prospectus for the Transfer of Listing from the LEAP Market to ACE Market  
Nov 26, 2024 13:40 HKT/SGT
S&P Acknowledges Fosun's Return to the USD Bond Market  
Nov 26, 2024 13:30 HKT/SGT
EdgePoint Infrastructure Inks Strategic Partnership with CelcomDigi to expand connectivity in Malaysia at TowerXchange Meet Up Asia 2024  
Nov 26, 2024 13:00 HKT/SGT
GoKardz Launches Enterprise Module to Revolutionize Digital Business Card Management Empowering Businesses with Comprehensive Digital Networking Solutions  
Nov 26, 2024 13:00 HKT/SGT
Propel Global Reports Encouraging 24.2% Growth in Revenue to RM34.3 Million in Q1 FY2025  
Nov 26, 2024 11:00 HKT/SGT
Fujitsu develops Policy Twin, a new digital twin technology to maximize effectiveness of local government policies for solving societal issues  
Tuesday, November 26, 2024 9:51:00 AM
GoDaddy's Airo solution is helping Asian entrepreneurs save time   
Nov 26, 2024 08:00 HKT/SGT
Hola Prime Sets New Industry Standard as the World's Top Transparent Prop Trading Firm  
Nov 25, 2024 22:00 HKT/SGT
Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled  
Nov 25, 2024 22:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575